All relevant data are within the paper and its Supporting Information files.

Introduction {#sec007}
============

Refractive surgery is being performed for more than 30 years and is considered to be the safest and most favorable option for vision correction in myopic eyes \[[@pone.0208608.ref001]\].

These procedures are known to be very safe and highly effective, yet there are still many concerns regarding their safety and efficacy \[[@pone.0208608.ref002]--[@pone.0208608.ref003]\]. Loss of Best Corrected Visual Acuity (BSCVA) of more than one line was reported in 0.06%-0.1% and up to 0.4% in some reports. Severe complications were reported with very low rate--ectasia in up to 0.6%, stromal flap complications in up to 1.0% (in LASIK (laser assisted in situ keratomileusis) procedures) and recurrent corneal erosions in up to 0.08%. Postoperative UCVA (uncorrected Visual acuity) of 20/20 or better was reported in 70% of procedures and UCVA of 20/40 or better was reported in 90--95% of procedures \[[@pone.0208608.ref003]--[@pone.0208608.ref007]\].

Although laser refractive procedures have been practiced worldwide for almost 30 years, no study investigating the predictive factors for success in both safety and efficacy has been published yet. Success rates of these procedures, differences between PRK (Photo Refractive Keratectomy) and LASIK procedures, and post-operative complications and their treatments are commonly reported. Many studies investigated the outcome of refractive procedures, and some of these included large cohorts such as Baviera J et al. and several Cochrane reviews \[[@pone.0208608.ref004],[@pone.0208608.ref008]--[@pone.0208608.ref012]\]. However, none of them has investigated the preoperative factors predicting the safety and efficacy outcomes. Therefore, in our study, we evaluated the predictive factors for safety and efficacy of refractive surgery procedures.

The purpose of this study was to evaluate the predictive factors for safety and efficacy in laser refractive surgery for myopia. We investigated these factors using a large database of patients at the refractive center of the Department of Ophthalmology in Hadassah-Hebrew University Medical Center. The Hadassah Refractive center is characterized by a small fixed team of surgeons and using the same manufacturer for the excimer laser hardware and software over the years. The laser system in use was Bausch and Lomb Keracor 217z excimer laser and since 2007 the Zyoptix wavefront guided system was used. These characteristics enable reliable analysis of retrospective data with relatively minimal bias.

This study included a relatively large cohort of patients which were operated over a span of 13 years. A novel analysis system was used to evaluate safety and efficacy, using clinically significant cut-off values for the safety and efficacy indices.

Methods {#sec008}
=======

This cohort study adhered to the tenets of the Declaration of Helsinki and was approved by the Hadassah Medical Center IRB (no. 0083-17-HMO). All data were fully anonymized before we accessed them.

Data collection {#sec009}
---------------

Data was collected from the medical records at the Hadassah Refractive Surgery Center. A retrospective database of 22,610 laser refractive procedures for myopia (in 11,834 patients) which were performed at Hadassah Refractive Surgery Center during the years 2002 through 2015 was available for this study. Data from pre-operative and follow-up visits was collected and analyzed. For each eye, parameters such as gender, age, type of surgery, date of surgery, pre-operative central corneal thickness and pre-operative Spherical Equivalent (SEQ) were evaluated. UCVA and BCVA were collected from follow-up visits.

Exclusion criteria included: patients who had refractive surgeries for hyperopia. Patients with incomplete data were excluded from the analysis. Manual scanning was performed to identify and delete duplications and mistakes. Missing data was completed by using the patients' files. Only surgeries with follow-up visits between three to twelve months were included in this study and among those visits, the latest follow-up visit was used. Patients with keratoconus or other corneal pathologies were not operated.

Study population {#sec010}
----------------

The initial sample included data from 22,610 consecutive laser refractive procedures for myopia and hyperopia. Excluded procedures included 6,883 due to insufficient data details (BCVA, UCVA, surgery type), 828 hyperopic procedures, and 5,837 with insufficient follow up of 3--12 months. Following these exclusions, the sample included data on 8,775 refractive procedures for myopia.

The pre-operative SEQ was divided into four groups based on the magnitude of myopia: low myopia (0 to -3 D), moderate myopia (-3.01 to -6 D), high myopia (-6.01 to -9 D) and very high myopia (\>-9.01 D) \[[@pone.0208608.ref002],[@pone.0208608.ref003],[@pone.0208608.ref009],[@pone.0208608.ref013]\]. Treatment dates were divided into three time periods based on the introduction of Wavefront technology: 2002 to 2006 when Wavefront technology was not available, 2007--2010 when Wavefront technology was optional, and 2011--2015 when it was mandatory in all patients.

The decision whether to perform LASIK or PRK surgery was made according to the usual criteria including the expected residual stromal bed thickness, the corneal topography, and the patients occupation and lifestyle. We wanted to preserve a residual stromal bed thickness of 250 μ at the end of the surgery. Therefore, patients with high myopia or with thin corneas underwent PRK surgery most of the times. Among patients with asymmetric topography at the inferior-superior axis, we avoided performing LASIK in order to prevent ectasia. Moreover, if a patient preferred one of the procedures due to his/her occupation or lifestyle, we accepted their requests.

Outcome measures {#sec011}
----------------

The two major outcome measures were the Safety Index and Efficacy Index at last follow-up visit. The Safety Index was defined as BSCVA after treatment divided by BSCVA before treatment (BSCVA post/BSCVA pre). The Efficacy Index was defined as UCVA after treatment divided by BSCVA before treatment (UCVA post/BCVA pre).

Cut-off levels of 0.85 for the Safety index and 0.80 for the Efficacy index were set to determine successful results at last follow-up for these two indices, respectively. Values with safety index above the 0.85 cut-off indicate loss of less than two lines, while values below the 0.85 cut-off level indicate loss of two or more lines, which was not acceptable by most refractive surgeons for BSCVA after surgery. While a loss of one line may seem acceptable, loss of two lines usually indicates a lack of success regarding the safety of these procedures \[[@pone.0208608.ref004],[@pone.0208608.ref014]--[@pone.0208608.ref015]\].

Values with efficacy index above the 0.8 cut-off indicate loss of up to two lines of UCVA, which most patients could be tolerable, while values below the 0.8 cut-off level indicate loss of more than two lines, where both surgeons and patients may be concerned about. Loss of more than two lines is the point that usually indicates a lack of success regarding the efficacy of these procedures \[[@pone.0208608.ref015]--[@pone.0208608.ref016]\].

Statistical analysis {#sec012}
--------------------

Statistical analysis was performed using SPSS statistical software, version 22.0 (IBM SPSS statistics). The t-test was used to compare ages between two categories of the dichotomous outcome dependent variables (safety and efficacy). Uni-variate analysis using Chi-Square test was performed to assess the effects on safety and efficacy of refractive surgeries by various qualitative variables (gender, treatment type, treatment period and SEQ before treatment). Multivariate analysis was performed using multiple logistic regression analysis, using the Forward Stepwise Likelihood Ratio method, to investigate the effects of several variables simultaneously, on the safety and efficacy indices. All P-values were 2 tailed and significance level of 0.05 or less was considered statistically significant.

Results {#sec013}
=======

We evaluated 8,775 eyes of 4,623 patients at the last follow-up visit, which took place 3--12 months after having refractive eye surgery. Of these, 2,197 were males (47.5%) and 2426 females (52.5%). The average age of the patients was 28.6 ± 8.7 years (range 17.3--67.2 years). The mean SEQ before treatment was -4.76 D (range \[-16.02\]-\[-0.02\] diopters). The mean central corneal thickness before treatment was 529.6 μ (range 442--654 μ). Off all eyes, 3,884 eyes had PRK surgeries (44.3%) while 4891 eyes had LASIK surgeries (55.7%) ([Table 1](#pone.0208608.t001){ref-type="table"}).

10.1371/journal.pone.0208608.t001

###### Characteristics of the study population.

![](pone.0208608.t001){#pone.0208608.t001g}

  -------------------------------- -------------- --------------
  Age, y (mean, SD)                               28.6 ± 8.7
  Gender                                          
                                   Female         4576 (52.1%)
                                   Male           4198 (47.8%)
  SEQ, D (mean, SD)                               -4.76 ± 2.38
  Corneal thickness μ (mean, SD)   529.6 ± 33.8   
  Procedure                                       
                                   PRK            3884 (44.3%)
                                   LASIK          4891 (55.7%)
  Treatment period                                
                                   2002--2006     4276 (48.7%)
                                   2007--2010     2883 (32.9%)
                                   2011--2015     1614 (18.4%)
  -------------------------------- -------------- --------------

SEQ = spherical equivalent; PRK = photorefractive keratectomy; LASIK = laser assisted in situ keratomileusis; SD = standard deviation

The pre-operative SEQ and treatment periods were divided into four categories. The pre-operative SEQ categories were 0 to (-3) D, (-3.01) to (-6) D, (-6.01) to (-9) D and higher than (-9.01) D ([Table 2](#pone.0208608.t002){ref-type="table"}). Most eyes had SEQ up to (-6) (74.8%) and only a small group had SEQ higher than (-9.01) (6.1%). The surgeries were performed between 2002 and 2015 and treatment periods were divided into 3 time periods: 4276 eyes (48.7%) were operated during 2002--2006, 2883 eyes (32.95%) on 2007--2010 and 1614 eyes (18.4%) at 2011--2015 ([Table 1](#pone.0208608.t001){ref-type="table"}).

10.1371/journal.pone.0208608.t002

###### SEQ before treatment, categorized.

![](pone.0208608.t002){#pone.0208608.t002g}

                            Count   Percentage
  ----- ------------------- ------- ------------
  SEQ   0 to (-3) D         2298    26.2%
        (-3.01) to (-6) D   4269    48.6%
        (-6.01) to (-9) D   1675    19.1%
        \> -9 D             533     6.1%

SEQ = spherical equivalent

The major outcome measures were the safety index and efficacy index at last follow-up visit. The overall mean Safety Index for all procedures was 1.03±0.13 and the overall mean Efficacy Index for all procedures was 0.97±0.2. A cut-off level of 0.85 for the safety index and 0.80 for the efficacy index were set to determine successful results. Of all procedures, 715 (8.1%) were below the Safety cut-off level, and 1229 (14%) were below Efficacy cut-off level ([Table 3](#pone.0208608.t003){ref-type="table"}).

10.1371/journal.pone.0208608.t003

###### Success of safety and efficacy.

![](pone.0208608.t003){#pone.0208608.t003g}

                                         Count   Percentage
  ---------- --------------------------- ------- ------------
  Safety     Above cut-off (\>0.85)      8060    91.9%
             Below cut-off (\< = 0.85)   715     **8.1%**
  Efficacy   Above cut-off (\>0.8)       7546    86%
             Below cut-off (\< = 0.8)    1229    **14%**

The effects of several dichotomous independent variables on the Safety and Efficacy indices were evaluated. First, univariate analysis was used to evaluate the effects of the different independent variables (such as age, gender, pre-operative SEQ, corneal thickness, treatment type and treatment period) on the Safety and Efficacy indices.

Univariate analysis {#sec014}
-------------------

### Age at the time of surgery {#sec015}

Younger age was significantly correlated with safety and efficacy indices above the cut-off levels using a T-Test (P\<0.001, 2-tailed). Mean age for patients above safety and efficacy cut-off levels (28.3±8.49, 28.0±8.20 years respectively) was significantly younger than for patients below cut-off levels (32.0±10.3, 32.4±10.58 years respectively) ([Table 4](#pone.0208608.t004){ref-type="table"}).

10.1371/journal.pone.0208608.t004

###### Correlation between age and safety and efficacy (T-Test).

![](pone.0208608.t004){#pone.0208608.t004g}

                                                       [Age before treatment]{.ul}                    
  ------------------------ --------------------------- ----------------------------- ------- -------- --------------
  **Safety**               Below cut-off (\< = 0.85)   714                           32.02   10.303   **p\<0.001**
  Above cut-off (\>0.85)   8039                        28.31                         8.49             
  **Efficacy**             Below cut-off (\< = 0.8)    1222                          32.38   10.59    **p\<0.001**
  Above cut-off (\>0.8)    7531                        28.00                         8.21    ** **    

P-value indicates association between age and outcome above/below cut-off.

Gender {#sec016}
------

Male gender was significantly correlated with efficacy above the cut-off level using Pearson Chi-Square test (P\<0.001, 2-sided). 12.0% of male's eyes were below efficacy cut-off level compared to 15.8% of female's eyes (p\<0.001). 7.9% of male's eyes were below safety cut-off compared to 8.3% of female's eyes (p = 0.5) ([Table 5](#pone.0208608.t005){ref-type="table"}).

10.1371/journal.pone.0208608.t005

###### Correlation between gender and safety and efficacy (Pearson Chi-Square).

![](pone.0208608.t005){#pone.0208608.t005g}

                Safety       Efficacy                                                  
  ------------- ------------ ------------ ------------ -------- --------- ----- ------ --------------
  Gender        Male eyes    Percentage   333          3865     p = 0.5   503   3695   **p\<0.001**
  Count         **7.90%**    92.10%       **12.00%**   88.00%                          
  Female eyes   Percentage   381          4195         725      3851                   
  Count         **8.30%**    91.70%       **15.80%**   84.20%                          

P-value indicates association between gender and outcome above/below cut-off.

SEQ before treatment {#sec017}
--------------------

Refractive surgeries were performed on myopic eyes with SEQ ranging from 0 to -16 D. Lower SEQs were associated with both safety (p = 0.002) and efficacy (p\<0.001) indices above the cut-offs using Pearson Chi-Square test. In the group of SEQ 0 to (-3) D 198 eyes (8.6%) were below the safety cut-off, in the group of SEQ (-3.01) to (-6) D 311 eyes (7.3%), in the group of SEQ (-6.01) to (-9) D 143 eyes (8.5%), and in the group of SEQ \> -9 D 63 eyes (11.8%)--were below the safety cut-off ([Table 6](#pone.0208608.t006){ref-type="table"})([Fig 1](#pone.0208608.g001){ref-type="fig"}).

![Association between SEQ before treatment and eyes below efficacy and safety cut-off levels using univariate analysis and Pearson Chi-Square test (p = 0.002 for safety, p\<0.001 for efficacy). SEQ = spherical equivalent.](pone.0208608.g001){#pone.0208608.g001}

10.1371/journal.pone.0208608.t006

###### Correlation between SEQ before treatment and safety and efficacy (Pearson Chi-Square).

![](pone.0208608.t006){#pone.0208608.t006g}

                         Safety              Efficacy                                                              
  ---------------------- ------------------- ------------ ------------ ----------- --------------- -------- ------ --------------
  SEQ before treatment   0 to (-3) D         Percentage   198          2100        **p = 0.002**   188      2110   **p\<0.001**
                         Count               **8.60%**    91.40%       **8.20%**   91.80%                          
  (-3.01) to (-6) D      Percentage          311          3958         458         3811                            
                                             Count        **7.30%**    92.70%      **10.70%**      89.30%          
                         (-6.01) to (-9) D   Percentage   143          1532        386             1289            
                                             Count        **8.50%**    91.50%      **23.00%**      77.00%          
                         SEQ \>-9 D          Percentage   63           470         197             336             
                                             Count        **11.80%**   88.20%      **37.00%**      63.00%          

SEQ = spherical equivalent

P-value indicates association between SEQ before treatment and outcome above/below cut-off.

In the group of SEQ 0 to (-3) D 188 (8.2%) eyes were below efficacy cut-off, in the group of SEQ (-3.01) to (-6) D 458 eyes (10.7%), in the group of SEQ (-6.01) to (-9) D 386 eyes (23.0%) and 197 eyes (37.0%) in the group of SEQ\> -9 D were all bellow the efficacy cut off level. Higher SEQ before treatment was significantly associated with lower efficacy (p\<0.001) ([Table 6](#pone.0208608.t006){ref-type="table"}) ([Fig 1](#pone.0208608.g001){ref-type="fig"}).

Treatment type {#sec018}
--------------

Two types of refractive procedures were performed, PRK and LASIK. The surgical procedure was found to significantly affect the outcome: safety was found significantly higher in PRK, while efficacy was found significantly higher in LASIK using Pearson Chi-Square test (P\<0.001, respectively). 6.2% of PRK surgeries were below safety cut-off level in comparison with 9.7% of LASIK surgeries (P\<0.001). 17.0% of PRK surgeries were below efficacy cut-off levels in comparison with 11.6% of LASIK surgeries (P\<0.001). ([Table 7](#pone.0208608.t007){ref-type="table"})([Fig 2](#pone.0208608.g002){ref-type="fig"}).

![Association between treatment type and eyes below safety and efficacy cut-off levels using univariate analysis and Pearson Chi-Square test (p\<0.001 for both safety and efficacy).\
PRK = photorefractive keratectomy; LASIK = laser assisted in situ keratomileusis.](pone.0208608.g002){#pone.0208608.g002}

10.1371/journal.pone.0208608.t007

###### Correlation between treatment type and safety and efficacy (Pearson Chi-Square).

![](pone.0208608.t007){#pone.0208608.t007g}

                   Safety       Efficacy                                                       
  ---------------- ------------ ------------ ------------ -------- -------------- ----- ------ --------------
  Treatment type   PRK          Percentage   242          3642     **p\<0.001**   660   3224   **p\<0.001**
  Count            **6.2%**     93.8%        **17.00%**   83.00%                               
  LASIK            Percentage   473          4418         569      4322                        
  Count            **9.7%**     90.3%        **11.6%**    88.4%                                

SEQ = spherical equivalent; LASIK = laser assisted in situ keratomileusis

P-value indicates association between treatment type and outcome above/below cut-off.

Corneal thickness {#sec019}
-----------------

Thinner corneas significantly correlated with the Safety index above the cut-off using T-test (p = 0.003, 2-tailed), but did not significantly affect Efficacy index (p = 0.263). Mean corneal thickness was 529μ for safety index above the cut-off level and 532μ below the cut-off level ([Table 8](#pone.0208608.t008){ref-type="table"}).

10.1371/journal.pone.0208608.t008

###### Correlation between corneal thickness and safety and efficacy (T-Test).

![](pone.0208608.t008){#pone.0208608.t008g}

                                             [Corneal thickness]{.ul}                    
  -------------- --------------------------- -------------------------- -------- ------- ---------------
  **Safety**     Below cut-off (\< = 0.85)   714                        533.23   32.89   **p = 0.003**
                 Above cut-off (\>0.85)      8042                       529.34   33.91   
  **Efficacy**   Below cut-off (\< = 0.8)    1229                       528.65   34.56   **p = 0.263**
                 Above cut-off (\>0.8)       7527                       529.82   33.73   ** **

P-value indicates association between corneal thickness and outcome above/below cut-off.

Treatment period {#sec020}
----------------

Refractive surgeries were performed during 2002 to 2015. Safety index above the cut-off level was increased over the years while efficacy index was found higher in 2002--2006 than the later periods 2007--2010 and 2011--2015 using Pearson Chi-Square test (P\<0.001, 2-sided). In 2002--2006 12.9% of safety indices were below cut-off level, 4.4% in 2007--2010 and 2.3% in 2011--2015. In 2002--2006 11.5% of efficacy indices were below cut-off level, 16.4% in 2007--2010 and 16.4% in 2011--2015 ([Table 9](#pone.0208608.t009){ref-type="table"})([Fig 3](#pone.0208608.g003){ref-type="fig"}).

![Association between treatment period and patients below safety and efficacy cut-off levels using univariate analysis and Pearson Chi-Square test (p\<0.001 for both safety and efficacy).](pone.0208608.g003){#pone.0208608.g003}

10.1371/journal.pone.0208608.t009

###### Correlation between treatment period and safety and efficacy (Pearson Chi-Square).

![](pone.0208608.t009){#pone.0208608.t009g}

                     Safety       Efficacy                                                 
  ------------------ ------------ ------------ ------- ------- -------------- ----- ------ --------------
  Treatment period   2002--2006   Percentage   551     3725    **p\<0.001**   491   3785   **p\<0.001**
  Count              12.9%        87.1%        11.5%   88.5%                               
  2007--2010         Percentage   127          2756    472     2411                        
  Count              4.4%         95.6%        16.4%   83.6%                               
  2011--2015         Percentage   37           1577    264     1350                        
  Count              2.3%         97.7%        16.4%   83.6%                               

P-value indicates association between treatment period and outcome above/below cut-off.

Multivariate analysis {#sec021}
---------------------

Logistic Regression Model was used in order to evaluate the association between pre-operative factors (categorical and non-categorical) and the safety and efficacy indices. Only significant factors from the univariate analysis were tested in the logistic regression model.

Safety {#sec022}
------

8,734 (99.5%) cases were analyzed out of the 8775 refractive procedures' sample. 41 cases were excluded because of missing data, necessary for completing the multivariate analysis. Four significant factors were included in the Logistic Regression Model ([Table 10](#pone.0208608.t010){ref-type="table"}):

10.1371/journal.pone.0208608.t010

###### Logistic regression model--safety.

![](pone.0208608.t010){#pone.0208608.t010g}

  Variable                   Sig.                Adjusted OR    95% C.I. for OR                           
  -------------------------- ------------------- -------------- ----------------- ----------------------- -------
  **Age**                                        **p\<0.001**   **0.969**         0.961                   0.977
  **SEQ before Treatment**   0 to (-3) D         **p\<0.001**   **3.293**         2.367                   4.581
  (-3.01) to (-6) D          **p\<0.001**        **3.634**      2.651             4.981                   
                             (-6.01) to (-9) D   **p\<0.001**   **2.138**         1.533                   2.982
                             SEQ\> -9 D          **p\<0.001**   **1.0**           \* reference category   
  **Treatment period**       2002--2006          **p\<0.001**   **1.0**           \* reference category   
  2007--2010                 **p\<0.001**        **3.577**      2.889             4.429                   
  2011--2015                 **p\<0.001**        **7.598**      5.353             10.785                  

SEQ = spherical equivalent; OR = odds ratio; C.I = confidence interval

SEQ before treatment and treatment period---OR value is regarding the reference category. Age---OR value is relative to an increase of one year

### Age {#sec023}

Increasing age was found associated to decreasing Safety with an OR (Odds Ratio) of 0.97 (95% CI 0.96--0.98) (p\<0.001). OR value is relative to an increase of one year.

### Treatment period {#sec024}

Safety index above the cut-off level was found to be significantly increasing over the years. OR value is regarding the reference category of 2002--2006. The group of 2007--2010 has an OR of 3.58 (95% CI 2.89--4.43) (p\<0.001) and the group of 2011--2015 has an OR of 7.59 (95% CI 5.35--10.78) (p\<0.001) ([Fig 4](#pone.0208608.g004){ref-type="fig"}).

![Relation between treatment periods and OR (Odds Ratio) for eyes above safety index cut-off level using multivariate analysis and logistic regression model (p\<0.001).\
OR value is regarding the reference category.](pone.0208608.g004){#pone.0208608.g004}

### SEQ before treatment {#sec025}

In myopic eyes, lower SEQ was found to be significantly associated with an increasing safety index above the cut-off level. OR value of 1 was assigned for the category of SEQ\> -9 D. The group of SEQ between 0 to (-3) D had an OR of 3.29 (95% CI 2.37--4.58) (p\<0.001), the group of SEQ (-3.01) to (-6) D had an OR of 3.63 (95% CI 2.65--4.98) (p\<0.001) and the group of SEQ (-6.01) to (-9) D had an OR of 2.14 (95% CI 1.53--2.98) (p\<0.001) ([Fig 5](#pone.0208608.g005){ref-type="fig"}).

![Relation between SEQ before treatment and OR for eyes above safety index cut-off level using multivariate analysis and logistic regression model (p\<0.001).\
OR value is regarding the reference category. SEQ = spherical equivalent.](pone.0208608.g005){#pone.0208608.g005}

### Corneal thickness {#sec026}

Was not associated with a safer outcome (p = 0.48).

Efficacy {#sec027}
--------

8,752 (99.1%) cases were analyzed out of the 8775 refractive procedures' sample. 23 cases were excluded because of missing data, necessary for completing the multivariate analysis. Four significant factors were included in the Logistic Regression Model ([Table 11](#pone.0208608.t011){ref-type="table"}): age, treatment period, pre-operative SEQ and gender.

10.1371/journal.pone.0208608.t011

###### Logistic regression model--efficacy.

![](pone.0208608.t011){#pone.0208608.t011g}

                                             Sig.            Adjusted OR   95% C.I. for OR         
  -------------------------- --------------- --------------- ------------- ----------------------- -------
  **Age**                                    **p\<0.001**    0.943         0.937                   0.949
  **SEQ before Treatment**   0 to (-3) D     **p\<0.001**    6.420         5.018                   8.214
  SEQ \>-3 D to -6 D         **p\<0.001**    4.823           3.891         5.979                   
  SEQ \>-6 D to -9 D         **p\<0.001**    1.895           1.523         2.356                   
                             SEQ\> -9 D      **p\<0.001**    1.0           \* reference category   
  **Treatment period**       2002--2006      **p\<0.001**    1.0           \* reference category   
  2007--2010                 **p\<0.001**    0.711           0.611         0.828                   
  2011--2015                 **p = 0.017**   0.804           0.673         0.962                   
  **Gender**                 Male            **p = 0.017**   1.170         1.028                   1.332

SEQ = spherical equivalent; OR = odds ratio; C.I = confidence interval

SEQ before treatment and treatment period---OR value is regarding the reference category. Age---OR value is relative to an increase of one year. Gender--OR value is regarding female gender.

### Age {#sec028}

Increasing age was found associated to decreasing efficacy with an OR of 0.94 (95% CI 0.937--0.95) (p\<0.001). OR value is relative to an increase of one year.

### Treatment period {#sec029}

Efficacy index above cut-off level was found higher in 2002--2006 than the later periods 2007--2010 and 2011--2015. OR value is regarding the reference category of 2002--2006. The group of 2007--2010 has an OR of 0.71 (95% CI 0.61--0.83) (p\<0.001) and the group of 2011--2015 has an OR of 0.804 (95% CI 0.673--0.962) (p = 0.017) ([Fig 6](#pone.0208608.g006){ref-type="fig"}).

![Relation between treatment period and OR for eyes above efficacy index cut-off level using Multivariate analysis and Logistic regression model (p\<0.001 for 2007--2010 period; P = 0.017 for 2011--2015 period).\
OR value is regarding the reference category.](pone.0208608.g006){#pone.0208608.g006}

### SEQ before treatment {#sec030}

In myopic eyes, low SEQ was found to be associated with a higher efficacy index above cut-off level. OR value is regarding the reference category of SEQ \> -9 D. The group of SEQ between 0 to (-3) D has an OR of 6.42 (95% CI 5.02--8.21) (p\<0.001), the group of SEQ (-3.01) to (-6) D has an OR of 4.82 (95% CI 3.89--5.98) (p\<0.001) and the group of SEQ (-6.01) to (-9) D has an OR of 1.89 (95% CI 1.52--2.36) (p\<0.001) ([Fig 7](#pone.0208608.g007){ref-type="fig"}).

![Relation between SEQ before treatment and OR for eyes above efficacy index cut-off level using multivariate analysis and logistic regression model (p\<0.001).\
OR value is regarding the reference category. SEQ = spherical equivalent.](pone.0208608.g007){#pone.0208608.g007}

### Gender {#sec031}

The Male gender was found weakly associated to increasing efficacy index above cut-off level with an OR of 1.17 (95% CI 1.03--1.33) (p = 0.017). OR value is regarding the reference category of female.

### Treatment type {#sec032}

Multiple regression analysis found no differences of safety and efficacy between LASIK and PRK (P = 0.201).

Discussion {#sec033}
==========

Refractive surgery techniques have become a common treatment for the correction of refractive errors in myopic eyes. Outcomes, differences between PRK and LASIK procedures, and post-operative complications and their treatments are commonly reported. However, no study investigating the various predictive factors for success in safety and efficacy in these procedures has been published so far. Therefore, in our study, we evaluated the predicting factors by using a novel outcome method of preset cut-off levels (0.85 and 0.8 respectively). The strength of this study was by using a relatively large prospective sample size, including data available for 8,775 refractive procedures, performed in the same institute during the span of 13 consecutive years by a small fixed group of surgeons.

Complications of refractive surgeries were not discussed in this paper. We believe that complications should be investigated and addressed separately, and merit separate studies, devoted just to the understanding of those complications. Retreatment procedures, although performed by our team, were excluded from this study as it was not our main goal and should be discussed separately. As described before, our novel concept was to evaluate the overall predictive factors for efficacy and safety instead of discussing different complications and long term outcomes. Our goal in this study was rather to focus on factors that affect the overall result in a large cohort of patients. According to our belief, the success in safety and efficacy of these surgeries resulted from the different pre-operative factors that are investigated in our study rather than major complications.

An accurate knowledge of the safety and efficacy of refractive surgery procedures is a basic requirement for each refractive surgery service. Each refractive surgeon must be able to analyze the results of his procedures for the purpose of improving his practice, as well as for the need for patient information prior to deciding to undergo a refractive procedure. In our study we used the safety and efficacy indices for these purposes. These parameters give a simple, accurate and inclusive information on the safety and efficacy of refractive procedures, without specifically analyzing individual complications and side effects which might occur in various occasions. We believe that complications and side effects of refractive surgery may affect these indices, and may be reflected in the overall outcome.

In this study, analyzing 8,775 refractive surgeries for myopia, efficacy was found to be significantly correlated with younger age, male gender and low myopia. Safety was found to be significantly correlated with younger age, low myopia and to be significantly increasing over the years. Corneal thickness was found to be correlated with safety only by using uni-variate analysis. PRK procedures were safer compared to LASIK, while LASIK procedures were more effective compared to PRK procedures, using the uni-variate analysis. However, multiple regression analysis found no differences of safety and efficacy between these two refractive procedures. 91.9% and 86.0% of all evaluated eyes were above the safety and efficacy cut-off levels, respectively.

This study is the first to evaluate predictive factors for success in safety and efficacy of refractive surgeries using a novel evaluation system, for the analysis of a prospective large study cohort. In our study, the influence of confounders such as surgeons and equipment was minimized by having a small and fixed team of surgeons performing surgeries using similar techniques over the years. A new cut-off method was used for evaluating predictive factors, indicating percentages below and above cut-off levels of the safety and efficacy indices. Describing surgeries outcomes using cut-off levels is very meaningful to clinicians. Cut-off levels of 0.85 for the Safety index and 0.80 for the Efficacy index were set. Values below the safety 0.85 cut-off level indicates loss of two or more lines that is not acceptable for the BSCVA after an elective refractive surgery. Values below the efficacy 0.8 cut-off level indicates loss of more than two lines of UCVA, a level which may be unsatisfactory for patients anxious to achieve an optimal level of UCVA.

Age {#sec034}
---

Younger age was significantly correlated with safety and efficacy indices above the cut-off levels using uni and multivariate analysis. This result can be attributed to healing properties of the cornea which are influenced by epithelial migration and proliferation processes, which are known to be better and faster in younger patients \[[@pone.0208608.ref017]--[@pone.0208608.ref020]\]. In younger people there is a higher amount of tears, the corneal sensitivity is higher and supports epithelial cells viability and proliferation. It was found that healing is slower and less extensive in mature corneas than in younger ones \[[@pone.0208608.ref017]\], older individuals have substantially slower recovery rates \[[@pone.0208608.ref018]\] and the aged cornea is slower to recover from hypoxic stress \[[@pone.0208608.ref020]\]. Currently there is no accepted upper age limit for refractive surgeries, and in our study only 13 patients (0.14%) were above sixty years old, none of whom had suffered from cataract or nuclear sclerosis. Younger patients under the age of eighteen were operated before military service only if their spherical equivalent was stable for at least twelve months.

Pre-operative SEQ {#sec035}
-----------------

In this study myopic eyes with lower SEQ were associated with both safety and efficacy indices above the cut-off levels. It is generally accepted that eyes with mild myopia have better BCVA and UCVA outcomes after having refractive surgeries than eyes with high myopia. Similar results were previously reported \[[@pone.0208608.ref004],[@pone.0208608.ref021]--[@pone.0208608.ref023]\]--a better UCVA at 6--12 months post-treatment was found in low to moderate myopia rather than moderate to high myopia \[[@pone.0208608.ref004]\] and higher percent with UCVA of 20/20 or better was found in low myopic eyes \[[@pone.0208608.ref022]\].

Refractive procedure {#sec036}
--------------------

We found no differences between these two refractive procedures regarding safety and efficacy. Using the multiple regression analysis, the safety and efficacy of these procedures were similar, although in the uni-variate analysis PRK was found safer, while LASIK was found more effective. There is controversy concerning safety and efficacy of those two procedures. Many studies claim LASIK is safer and more efficient over PRK while others claim they are comparable in all aspects \[[@pone.0208608.ref004],[@pone.0208608.ref024]\]. The differences may be caused by the change in different evaluation techniques. A comparison between the two techniques found similarity in safety and efficacy, however found that PRK induced statistically fewer higher-order aberrations than LASIK at 6 months \[[@pone.0208608.ref025]\]. The multiple regression analysis used in this study found no significant difference between the two procedures in similarity with most recent studies \[[@pone.0208608.ref004],[@pone.0208608.ref009],[@pone.0208608.ref026]\]. The different results in this study may be caused using uni-variate and multiple regression analysis.

Treatment period {#sec037}
----------------

Safety index above the cut-off level was significantly increased over the years. This is most probably explained by the increasing experience of the surgeons over the years, by performing better preoperative screening of patients with known risk factors for ectasia such as keratoconus, familial keratoconus history, and avoiding surgery on thin corneas and high myopia \[[@pone.0208608.ref004]\]. The use of Wavefront technology and newer laser technologies had contributed to the improved safety over the years as also reported in previous studies \[[@pone.0208608.ref004],[@pone.0208608.ref022]\]. Increased safety over the years could be also explained by using newer models of microkeratomes: specifically replacing the Hansatome microkeratome (Bausch & Lomb, Rochester, NY) used in LASIK surgeries with the newer Bausch & Lomb XP Microkeratome. Efficacy was found higher in the early period of 2002--2006 in comparison to later periods. This may reflect the increased proportion of PRK procedures compared to LASIK procedures at our institute during the years. In addition, the low OR value in this analysis indicates a weak correlation, as reflected by the relatively high P-value of 0.017 (although significant, this level of significance was generally much lower compared to the significance levels for the other parameters). In our study, the targeted refraction (the target refraction after surgery) remained unchanged during the entire study period. Younger patients were targeted to a slight overcorrection of +0.25 D while adults above 40 years were targeted to 0 D.

Gender {#sec038}
------

Male gender was found significantly correlated with efficacy above the cut-off level. This is the first study demonstrating such significant result by using a prospective large study cohort. This difference however, was found to have a much lower significance level on the multivariate analysis (p = 0.017), suggesting that it may be a coincident finding, resulting from the likelihood of finding significance by chance when using a large number of variables in a large cohort study. We could not find a reasonable explanation for these data, and could not find another study supporting this observation.

Corneal thickness {#sec039}
-----------------

In this study corneal thickness did not correlate with efficacy index above cut-off level and thicker corneas were found to have a negligible effect on safety index above cut-off level. This may reflect a tendency of our surgeons to prefer performing PRK surgery in patients with thinner corneas or to avoid operating patients with very thin corneas.

In summary, our large prospective study found that Efficacy in refractive surgery for myopia is significantly correlated with younger age, male gender and low myopia. Safety was correlated with younger age, low myopia and increases over the years with surgical experience. Multiple regression analysis found no differences of safety and efficacy between PRK and LASIK procedures. Corneal thickness did not affect the efficacy of refractive procedures and had a negligible effect on the safety in our study.

Our study has some limitations---We did not include data on complications and retreatments, as our aim was to focus mainly on the predictive factors, while avoiding the conventional outcome presentation charts. In addition, our study included a relatively long period in which important technological changes occurred in this field. However, we used this potential limitation to look at the effect of the surgery time period as one of the predictive variables. Moreover, we had a relatively high percentage of excluded patients due to missing data, as this is the nature of retrospective studies. A small portion of the study cohort had follow-up time of less than six months and even smaller portion with less than 3 months, however we expected only a slight difference between the results of six and twelve months \[[@pone.0208608.ref014]\].

This is the first study to use a large refractive surgery cohort of patients, evaluating pre-operative predictive factors for safety and efficacy in laser refractive surgeries for myopia, using a novel cut-off method for evaluating these factors. We believe that our results will help clinicians in better understanding the effects of the different pre-operative parameters on the success of these procedures, and will enable better pre-operative consultation, and improved decision making and patients selection. Further studies are needed to improve our understanding of the predictive factors for success in refractive surgeries for longer follow up periods, using our new method to predict safety and efficacy.

Supporting information {#sec040}
======================

###### This file contains the data of the patients.

(XLSX)

###### 

Click here for additional data file.

PRK

:   PhotoRefractive Keratectomy

LASIK

:   Laser ASsisted In situ Keratomileusis

SEQ

:   Spherical EQuivalent

OR

:   Odds Ratio
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